June A Ejlersen
Aarhus University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by June A Ejlersen.
Nuclear Medicine Communications | 2017
Randi F. Fonager; Helle Damgaard Zacho; Signe Albertsen; Joan Fledelius; June A Ejlersen; Mette H. Christensen; Ramune Aleksyniene; José Biurrun Manresa; Lars Jelstrup Petersen
Purpose The aim of this study was to assess observer agreement on the evaluation of treatment responses of bone metastases by bone scintigraphy (BS) using different scoring methods in prostate cancer patients. Patients and methods Sixty-three paired BS from 55 patients were included. BS was performed before and after more than 12 weeks of anticancer treatment. A panel of experienced nuclear medicine physicians from several institutions evaluated treatment response using three different methods: (a) standard clinical assessment, (b) MD Anderson criteria, and (c) Prostate Cancer Working Group 2 (PCWG-2) criteria. All methods were based on the evaluation of paired before–after bone scans. Results Readers were able to classify the presence of bone metastases at baseline with a high level of agreement [Cohen’s &kgr;=0.94, 95% confidence interval (CI) 0.82–1.00]. Observer agreement on bone response by PCWG-2 criteria showed considerable agreement (Cohen’s &kgr;=0.84, 95% CI: 0.69–0.99). Evaluation using standard clinical assessment and MD Anderson criteria showed moderate agreement (0.52, 95% CI: 0.36–0.69 and 0.64, 95% CI: 0.48–0.79, respectively). There was considerable variation among readers for regional lesion count on individual scans, with limits of agreement of −10 to 10 lesions or more for the majority of anatomical regions, including the thorax, spine, and pelvis. Conclusion Observer agreement on treatment response by BS varied notably across methods. Optimal agreement was achieved by the PCWG-2 criteria. Variation in the classification of treatment response of bone metastases may have a significant impact on clinical decision-making, emphasizing the need for a uniform approach, including during clinical practice. Response assessment by lesion counting on repeated BS without access to previous scans cannot be recommended.
Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2016
June A Ejlersen; Steen Hvitfeldt Poulsen; Jesper Mortensen; Ole May
Preinvasive risk stratification is recommended in patients suspected of coronary artery disease (CAD). Stress echocardiography (SE), myocardial perfusion scintigraphy (MPS), and exercise test are the dominant methods of choice. Vasodilator SE is fast and induces only minor increase in heart rate. The diagnostic value of the absolute stress–rest difference in endocardial global longitudinal strain (ΔeGLS) and wall motion (ΔWMI) from adenosine SE was compared to summed stress score (SSS) from MPS and Duke treadmill score (DTS) from exercise test, using quantitative invasive coronary angiography (ICA) as the reference.
Journal of Forensic Sciences | 2007
June A Ejlersen; Michel Dalstra; Lars Uhrenholt; Annie Vesterby Charles
ABSTRACT: A naked man died under peculiar circumstances and the postmortem examination revealed unexpected lesions in the cervical spine. Investigations of the cervical spine (computed tomography, magnetic resonance imaging, and histological examination) showed that a piece of bone was torn of the anterior part of vertebra C6 and that there was fresh bleeding in the surrounding tissue. The cause of death remained unclear but was most likely cardiac arrhythmia initiated by β‐2 agonist inhalation due to an acute asthmatic attack. Data from biomechanical investigation using finite element analysis supported the conclusion that the cervical spine injury was secondary to impact during falling as a consequence of the cardiac arrhythmia.
Acta Oncologica | 2018
Randi F. Fonager; Helle Damgaard Zacho; Niels Christian Langkilde; Joan Fledelius; June A Ejlersen; Helle Westergreen Hendel; Christian Haarmark; Mette Moe; Jesper Mortensen; Mads Ryø Jochumsen; Lars Jelstrup Petersen
Abstract Aim: To compare 18F-sodium fluoride positron emission tomography/computed tomography (NaF PET/CT) and 99mTc-labelled diphosphonate bone scan (BS) for the monitoring of bone metastases in patients with prostate cancer undergoing anti-cancer treatment. Material and methods: Data from 64 patients with prostate cancer were included. The patients received androgen-deprivation therapy (ADT), next-generation hormonal therapy (NGH) or chemotherapy. The patients had a baseline scan and 1–3 subsequent scans during six months of treatment. Images were evaluated by experienced nuclear medicine physicians and classified for progressive disease (PD) or non-PD according to the Prostate Cancer Working Group 2 (PCWG-2) criteria. The patients were also classified as having PD/non-PD according to the clinical and prostate-specific antigen (PSA) responses. Results: There was no difference between NaF PET/CT and BS in the detection of PD and non-PD during treatment (McNemar’s test, p = .18). The agreement between BS and NaF PET/CT for PD/non-PD was moderate (Cohen’s kappa 0.53, 95% confidence interval 0.26–0.79). Crude agreement between BS and NaF PET/CT for the assessment of PD/non-PD was 86% (89% for ADT, n = 28; 88% for NGH, n = 16, and 80% for chemotherapy, n = 20). In most discordant cases, BS found PD when NaF PET/CT did not, or BS detected PD on an earlier scan than NaF PET/CT. Biochemical progression (27%) occurred more frequently than progression on functional imaging (BS, 22% and NaF PET/CT, 14%). Clinical progression was rare (11%), and almost exclusively seen in patients receiving chemotherapy. Conclusion: There was no difference between NaF PET/CT and BS in the detection of PD and non-PD; however, BS seemingly detects PD by the PCWG-2 criteria earlier than NaF-PET, which might be explained by the fact that NaF-PET is more sensitive at the baseline scan.
Nuclear Medicine Communications | 2017
June A Ejlersen; Ole May; Jesper Mortensen; Gitte L Nielsen; Jeppe F Lauridsen; Johansen Allan
Objective Patients with normal stress perfusion have an excellent prognosis. Prospective studies on the diagnostic accuracy of stress-only scans with contemporary, independent examinations as gold standards are lacking. Patients and methods A total of 109 patients with typical angina and no previous coronary artery disease underwent a 2-day stress (exercise)/rest, gated, and attenuation-corrected (AC), 99m-technetium-sestamibi perfusion study, followed by invasive coronary angiography. The stress datasets were evaluated twice by four physicians with two different training levels (expert and novice): familiar and unfamiliar with AC. The two experts also made a consensus reading of the integrated stress-rest datasets. The consensus reading and quantitative data from the invasive coronary angiography were applied as reference methods. Results The sensitivity/specificity were 0.92–1.00/0.73–0.90 (reference: expert consensus reading), 0.93–0.96/0.63–0.82 (reference: ≥1 stenosis>70%), and 0.75–0.88/0.70–0.88 (reference: ≥1 stenosis>50%). The four readers showed a high and fairly equal sensitivity independent of their familiarity with AC. The expert familiar with AC had the highest specificity independent of the reference method. The intraobserver and interobserver agreements on the stress-only readings were good (readers without AC experience) to excellent (readers with AC experience). Conclusion AC stress-only images yielded a high sensitivity independent of the training level and experience with AC of the nuclear physician, whereas the specificity correlated positively with both. Interobserver and intraobserver agreements tended to be the best for physicians with AC experience.
EJNMMI research | 2017
Helle Damgaard Zacho; José Biurrun Manresa; Ramune Aleksyniene; June A Ejlersen; Joan Fledelius; Henrik Christian Bertelsen; Lars Jelstrup Petersen
EJNMMI research | 2013
Runa H Poulsen; Jan T. Rasmussen; June A Ejlersen; Christian Flø; Lise Falborg; Christian W. Heegaard; Michael Rehling
American journal of nuclear medicine and molecular imaging | 2017
Randi F. Fonager; Helle Damgaard Zacho; Niels C. Langkilde; Joan Fledelius; June A Ejlersen; Christian Haarmark; Helle Westergren Hendel; Mine Benedicte Lange; Mads Ryø Jochumsen; Jesper Mortensen; Lars J Petersen
European Journal of Nuclear Medicine and Molecular Imaging | 2018
Berit Dalsgaard Nielsen; Ib Hansen; Stine Kramer; Ate Haraldsen; Karin Hjorthaug; Trond Velde Bogsrud; June A Ejlersen; Lars B. Stolle; Kresten Krarup Keller; Philip Therkildsen; Ellen-Margrethe Hauge; Lars Christian Gormsen
International Journal of Cardiovascular Imaging | 2017
June A Ejlersen; Steen Hvitfeldt Poulsen; Jesper Mortensen; Ole May